Nanjing Hicin Pharmaceutical Co., Ltd.
SZSE:300584.SZ
24.7 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operationele Activiteiten: | ||||||||||||
Nettowinst
| 36.316 | 32.124 | 284.832 | 54.527 | 97.158 | 83.223 | 65.601 | 45.236 | 40.329 | 34.214 | 33.287 | 0 |
Afschrijvingen & Amortisatie
| 53.56 | 48.145 | 37.061 | 31.55 | 27.683 | 16.762 | 14.105 | 12.693 | 10.931 | 10.187 | 3.913 | 0 |
Uitgestelde Inkomstenbelasting
| -8.467 | -28.453 | 38.082 | -2.623 | -0.559 | 0.948 | -1.308 | -0.244 | 0.892 | 0 | 0 | 0 |
Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verandering in Werkkapitaal
| -72.853 | -102.453 | 34.314 | -23.174 | -36.782 | -27.664 | -30.865 | -23.322 | 1.391 | -23.255 | 7.421 | 0 |
Vorderingen
| -31.516 | -121.751 | -37.4 | -1.259 | -31.615 | -14.701 | -47.667 | -13.4 | 0.53 | -2.941 | -9.769 | 0 |
Voorraden
| -22.005 | -9.374 | 17.48 | 1.096 | -13.936 | -41.665 | 9.916 | -7.494 | 0.612 | -19.23 | 4.309 | 0 |
Crediteuren
| -19.332 | 57.125 | 16.152 | -20.388 | 9.328 | 27.753 | 8.193 | -2.183 | -0.643 | 0 | 0 | 0 |
Overig Werkkapitaal
| -27.799 | -28.453 | 38.082 | -2.623 | -0.559 | 14.001 | -40.782 | -15.827 | 0.779 | -4.025 | 3.112 | 0 |
Overige Niet-Contante Posten
| 195.35 | 16.365 | -296.266 | 10.486 | 9.218 | 4.889 | -2.282 | 3.13 | 1.251 | 3.148 | 0.543 | 0 |
Kasstroom uit Operationele Activiteiten
| 23.933 | -5.819 | 59.941 | 73.389 | 97.277 | 77.211 | 46.557 | 37.738 | 53.902 | 24.293 | 45.165 | 0 |
Investeringsactiviteiten: | ||||||||||||
Investeringen in Materiële Vaste Activa
| -197.222 | -218.941 | -94.41 | -120.103 | -43.362 | -76.672 | -66.518 | -45.629 | -28.631 | -29.068 | -41.608 | -68.027 |
Netto Overnames
| 0.648 | 0.077 | 0.041 | 120.284 | 43.386 | 76.787 | 69.551 | 0.001 | -1.476 | -14.124 | 0 | 0 |
Aankoop van Beleggingen
| -23 | -230 | -48.5 | -62 | -42 | -499.478 | -380.8 | 0 | 0 | 0 | 0 | 0 |
Verkoop/verval van Beleggingen
| 82.308 | 477.982 | 57.3 | 52.32 | 62.654 | 472.28 | 262.172 | 0 | 0 | 0 | 0 | 0 |
Overige Investeringsactiviteiten
| 59.956 | 0 | 0 | -120.103 | -43.362 | -76.672 | 3.032 | 0.001 | 0.257 | 0.609 | -0.198 | -68.027 |
Kasstroom uit Investeringsactiviteiten
| -137.266 | 29.118 | -85.569 | -129.602 | -22.684 | -103.757 | -182.114 | -45.628 | -29.85 | -42.584 | -41.806 | -68.027 |
Financieringsactiviteiten: | ||||||||||||
Schuldaflossingen
| -42.157 | -286 | -135 | -129 | -115.5 | -43.1 | -32.4 | -47.7 | -39.7 | -32 | -18 | -32 |
Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | -7.204 | 0 | 0 | 0 | 0 | 0 |
Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Uitgekeerde Dividenden
| -6.465 | -30 | -15 | -30 | -24 | -24.172 | -25.116 | -6.311 | -7.655 | -2.211 | -1.303 | -7.357 |
Overige Financieringsactiviteiten
| 22.914 | 279.466 | 194.098 | 175 | 120 | 120 | 243.153 | 42.4 | 37.7 | 46.4 | 22 | 81.188 |
Kasstroom uit Financieringsactiviteiten
| 65.071 | -42.034 | 37.082 | 9.012 | -25.463 | 52.728 | 185.637 | -11.611 | -9.655 | 12.189 | 2.697 | 41.831 |
Overige Informatie: | ||||||||||||
Effect van Wisselkoersveranderingen op Kas
| 0.017 | 0.008 | -0.061 | 0.014 | 0.004 | 0.001 | -0.002 | 0.002 | 0.001 | -0.073 | -0.049 | -0 |
Netto Kasstroomverandering
| -48.246 | -18.727 | 11.393 | -47.187 | 49.134 | 26.183 | 50.079 | -19.499 | 14.4 | -6.175 | 6.008 | 12.572 |
Kaspositie aan het Einde van de Periode
| 46.822 | 95.068 | 113.796 | 102.402 | 149.589 | 100.456 | 74.272 | 24.194 | 43.693 | 29.294 | 35.468 | 29.461 |